The Production of Therapeutic Proteins in Plants: Apo AI and Insulin

More documents

Recommendations

Info

Transformation of SafflowerGerminationSeedselectionInfection ofCotyledons byAgrobacteriumAcclimationto SoilEarly stagegrowth – noselectionRootingShoot Elongation& Selection
Field Grown GMO SafflowerPlanting sites: Alberta, United States and Chile -federal regulatory approval is required beforeplanting each season.Isolation distances are required – 1600 m from othersafflower crops in Canada, 2 miles in the US.Seed is harvested and cleaned before use.
Page 1 and 2: The Production of Therapeutic Prote
Page 3 and 4: SemBioSys OverviewLocation: Calgary
Page 5: SemBioSys’ TechnologyProof-of-Con
Page 9 and 10: Purification of OilbodiesThe Proces
Page 11 and 12: Plant Impurity AssaysPhytate (IP 6
Page 13 and 14: Product Impurity Assays - Fusion Pa
Page 15 and 16: Viral Load/Viral ClearanceRegulator
Page 17 and 18: InsulinPositioned to Meet the Growi
Page 19 and 20: Economics of Plant-Produced Insulin
Page 21 and 22: Insulin - Equivalence DataV8 Protea
Page 23 and 24: Insulin - Equivalence DataIGF-1 Rec
Page 25 and 26: Insulin Characterization: Clinical
Page 27 and 28: Apo AI Milano (SBS-2000)• FTO - S
Page 29 and 30: Functional Characterization of Puri
Page 31 and 32: Cholesterol Mobilization in vivoSBS
Page 33: Non-Pharma ProductsProducts and Com

The Production of Therapeutic Proteins in Plants: Apo AI and Insulin

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?